Health
Pfizer and BioNTech Propose Expansion of Pivotal COVID-19 Vaccine Trial – GlobeNewswire
NEW YORK and MAINZ, GERMANY, Sept. 12, 2020 (GLOBE NEWSWIRE) — NEW YORK and MAINZ, GERMANY, September 12 — Pfizer Inc. (NYSE: PFE) and BioNTech…
NEW YORK and MAINZ, GERMANY, Sept. 12, 2020 (GLOBE NEWSWIRE) —
NEW YORKand MAINZ, GERMANY, September 12 Pfizer Inc.
(NYSE: PFE) and BioNTech SE
(NASDAQ: BNTX) announced today that they have submitted an amended protocol to the U.S. Food and Drug Administration to expand the enrollment of their Phase 3 pivotal COVID-19 vaccine trial to up to approximately 44,000 participants which also allows for the enrollment of new populations.
Enrollment in the trial has been proceeding as planned an…
-
Noosa News21 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News19 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
General24 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
Business6 hours agoFord CEO makes stunning prediction about artificial intelligence